Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
Saved in:
| Title: | Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study. |
|---|---|
| Authors: | Kared H; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Jyssum I; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Alirezaylavasani A; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Egner IM; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., The Tran T; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway., Tietze L; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway., Lund KP; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tveter AT; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Ørbo H; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Haavardsholm EA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Vaage JT; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jørgensen K; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Syversen SW; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway., Goll GL; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Feb 22; Vol. 15, pp. 1296273. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38455062 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kared+H%22">Kared H</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jyssum+I%22">Jyssum I</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Alirezaylavasani+A%22">Alirezaylavasani A</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Egner+IM%22">Egner IM</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22The+Tran+T%22">The Tran T</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Tietze+L%22">Tietze L</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lund+KP%22">Lund KP</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Tveter+AT%22">Tveter AT</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Provan+SA%22">Provan SA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Ørbo+H%22">Ørbo H</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Haavardsholm+EA%22">Haavardsholm EA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Vaage+JT%22">Vaage JT</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jørgensen+K%22">Jørgensen K</searchLink>; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Syversen+SW%22">Syversen SW</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lund-Johansen+F%22">Lund-Johansen F</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Goll+GL%22">Goll GL</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Munthe+LA%22">Munthe LA</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Feb 22; Vol. 15, pp. 1296273. <i>Date of Electronic Publication: </i>2024 Feb 22 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38455062 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1296273 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1296273 Titles: – TitleFull: Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kared H – PersonEntity: Name: NameFull: Jyssum I – PersonEntity: Name: NameFull: Alirezaylavasani A – PersonEntity: Name: NameFull: Egner IM – PersonEntity: Name: NameFull: The Tran T – PersonEntity: Name: NameFull: Tietze L – PersonEntity: Name: NameFull: Lund KP – PersonEntity: Name: NameFull: Tveter AT – PersonEntity: Name: NameFull: Provan SA – PersonEntity: Name: NameFull: Ørbo H – PersonEntity: Name: NameFull: Haavardsholm EA – PersonEntity: Name: NameFull: Vaage JT – PersonEntity: Name: NameFull: Jørgensen K – PersonEntity: Name: NameFull: Syversen SW – PersonEntity: Name: NameFull: Lund-Johansen F – PersonEntity: Name: NameFull: Goll GL – PersonEntity: Name: NameFull: Munthe LA IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 02 Text: 2024 Feb 22 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
